Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference43 articles.
1. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery;Goyal;Ann Thorac Surg,2007
2. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts;N Engl J Med,1997
3. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators;Yusuf;N Engl J Med,2000
4. Efficacy of Long-Term beta-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery;Zhang;Circulation,2015
5. Aspirin and mortality from coronary bypass surgery;Mangano;N Engl J Med,2002
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Patient adherence after coronary bypass grafting: different facets of same matter. A systematic review;Kuban Scientific Medical Bulletin;2021-08-25
2. Effect of a smartphone-based intervention on secondary prevention medication prescriptions after coronary artery bypass graft surgery: The MISSION-1 randomized controlled trial;American Heart Journal;2021-07
3. The of effect of partnership-based education on adherence to the treatment plans in open heart surgery;Journal of Education and Health Promotion;2021
4. Quality Measurement and Improvement Study of Surgical Coronary Revascularization;Chinese Medical Journal;2018-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3